The role of gender differences and other client characteristics in the prevalence of DSM-IV affective disorders among a European therapeutic community population

Psychiatric Quarterly

Volumn 78, Issue 1, 2007, Pages 39-51

  De Wilde, Joke ^a   Broekaert, Eric ^a   Rosseel, Yves ^a   Delespaul, Philippe ^b   Soyez, Veerle ^a  

^a GHENT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Affective disorders; Client characteristics; Europe; Gender differences; Therapeutic community

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PATIENT ATTITUDE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; ROLE THEORY; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SUBSTANCE ABUSE;

ADULT; ANXIETY DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EUROPE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; SEX FACTORS; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; THERAPEUTIC COMMUNITY;

EID: 33846503337     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-006-9025-8     Document Type: Article

References (56)

1. Broekaert E, Slater A: The development of the early therapeutic community movement in Western and Southern Europe. EFTC newsletter, 7, 2001.
2. Janzen R: The Rise and Fall of Synanon: A California Utopia. Baltimore, London, The John Hopkins University Press, 2001.
3. De Leon G, Jainchill N: Psychiatric disorder in therapeutic community admission, in Bridging Services. Proceedings of the 9th World Conference of Therapeutic Communities. Edited by Acampora A, Nebelkopf E. San Francisco, Walden House, 1985.
4. De Leon G, Sacks S, Staines G, et al: Modified therapeutic community for homeless mentally ill chemical abusers: emerging subtypes. American Journal of Drug and Alcohol Abuse 25:495-515, 1999.
5. De Leon G: Phoenix House: psychopathological signs among male and female drug-free residents. Addictive Diseases 1:135-151, 1974.
6. Hendriks V: Addiction and psychopathology: a multidimensional approach to clinical practice, in European Addiction Research Institute. Rotterdam, European Addiction Research Institute, 1990.
7. De Leon G: The Therapeutic Community: Theory, Model, and Method. Springer Publishing Company, New York, 2000.
8. Carroll JFX, McGinley JJ: Managing MICA clients in a modified therapeutic community with enhanced staffing. Journal of Substance Abuse Treatment 15:565-577, 1998.
9. De Leon G, Sacks S, Staines G, et al: Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. American Journal of Drug and Alcohol Abuse 26:461-480, 2000.
10. Brown VB, Melchior LA, Waite-O'Brien N, et al: Effects of women-sensitive, long-term residential treatment on psychological functioning of diverse populations of women. Journal of Substance Abuse Treatment 23:133-44, 2002.
11. Messina N, Wish E, Nemes S: Predictors of treatment outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse 26:207-227, 2000.
12. Jainchill N, Hawke J, Yagelka J: Gender, psychopathology, and patterns of homelessness among clients in shelter-based therapeutic communities. American Journal of Drug and Alcohol Abuse 26:553-567, 2000.
13. Grella C, Joshi V, Hser Y: Follow-up of cocaine-dependent men and women with antisocial personality disorder. Journal of Substance Abuse Treatment 25:155-164, 2003.
14. De Leon G: Therapeutic communities: is there an essential model? in Community as Method: Therapeutic Communities for Special Populations and Special Settings. Edited by De Leon G. Westport (CT), Praeger Pub, 1997.
15. Broekaert E, Raes V, Kaplan CD, et al: The design and effectiveness of therapeutic community research in Europe: an overview. European Addiction Research 5:21-35, 1999.
16. Broekaert E, Van der Straten, D'Oosterlinck F, et al: The therapeutic community for ex-addicts: A view from Europe. International Journal for Therapeutic and Supportive Organisations 20:255-266, 1999.
17. Broekaert E, Kooyman M, Ottenberg DJ: The ''new'' drug-free therapeutic community. challenging encounter of classic and open therapeutic communities. Journal of Substance Abuse Treatment 15:595-597, 1998.
18. Ravndal E, Vaglum P: The influence of personality disorders on treatment completion in a hierarchical therapeutic community for drug abusers: a prospective study. European Addiction Research 1:178-186, 1995.
19. Ravndal E: Research in the concept-based therapeutic community - its importance to European treatment research in the drug field. International Journal of Social Welfare 12:229-238, 2003.
20. Ravndal E, Vaglum P: Changes in antisocial aggressiveness during treatment in a hierarchical therapeutic community. A prospective study of personality changes. Acta Psychiatrica Scandinavica 84:524-530, 1991.
21. Seivewright N, Daly C: Personality disorder and drug use: a review. Drug and Alcohol Review 16:235-250, 1997.
22. Kokkevi A, Stefanis N, Anastasopoulou E, et al: Personality disorders in drug abusers: prevalence and their association with axis I disorders as predictors of treatment retention. Addictive Behaviors 23:841-853, 1998.
23. De Wilde J, Soyez V, Broekaert E, et al: Problem severity profiles of substance abusing women in European therapeutic communities: influence of psychiatric problems. Journal of Substance Abuse Treatment 26:243-251, 2004.
24. Kaplan CD, Broekaert E: BIOMED II IPTRP Project. Improving Psychiatric Treatment in Residential Programmes for Emerging Dependency Groups. A European Social-psychiatric and Social-ecological Research and Development Project. Maastricht, Maastricht University, 1999.
25. Watters JK, Biernacki P: Targeted sampling - options for the study of hidden populations. Social Problems 36:416-430, 1989.
26. De Wilde J, Broekaert E, Segraeus V, et al: Is the "community as method" approach gender sensitive? Client and treatment characteristics in European therapeutic communities. Results of the BIOMED II (IPTRP) project. International Journal of Social Welfare 15: 150-161.
27. Broekaert E, Haack M, Kaplan CD, et al: The BIOMED II IPTRP project: implementation of diagnostic instruments. European Addiction Research 8:201-203, 2002.
28. Segraeus V, Broekaert E, Öberg D, et al: Implementing ASI and other instruments to professionalize treatment across national borders. Experiences from the IPTRP project. Journal of Substance Use 9:132-140, 2004.
29. Kokkevi A, Hartgers C: EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research 1:208-210, 1995.
30. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for DSM-IV Axis I Disorders - patient edition (SCID-I/P, version 2.0). New York, Biometrics Research Department, New York State Psychiatric Institute, 1996.
31. Broekaert E, Soyez V, Vanderplasschen W, et al: The videotaped addiction challenge tool: a new instrument for qualitative substance abuse assessment, treatment planning and research in therapeutic communities. International Journal of Social Welfare 10:134-141, 2001.
32. Frank O, Jansson I, Larsson J, et al: Addiction severity predictions using client network properties. International Journal of Social Welfare 10:215-223, 2001.
33. Kaplan C, Broekaert E, Morival M: Improving social psychiatric treatment in residential programmes for emerging dependence groups in Europe: cross-border networking, methodological innovations and substantive discoveries. International Journal of Social Welfare 10:127-133, 2001.
34. Ravndal E, Lauritzen G, Frank O, et al: Childhood maltreatment among Norwegian drug abusers in treatment. International Journal of Social Welfare 10:142-147, 2001.
35. Reichmann S, Kaplan CD, Jansson I: Social epidemiologic comparisons in a European cohort of substance-dependent therapeutic community clients: a case-oriented analysis. International Journal of Social Welfare 10:224-234, 2001.
36. McLellan AT, Luborsky L, Woody GE, et al: Improved diagnostic evaluation instrument for substance abuse patients - Addiction Severity Index. Journal of Nervous and Mental Disease 168:26-33, 1980.
37. McLellan AT, Kushner H, Metzger D, et al: The 5th edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199-213, 1992.
38. Spitzer RL, Williams JBW, Gibbon M, et al: The Structured Clinical Interview for DSM-III-R (SCID). History, rationale, and description. Archives of General Psychiatry 49:624-629, 1992.
39. European Monitoring Centre for Drugs and Drug Addiction: Co-morbidity - drug use and mental disorders. European Monitoring Centre for Drugs and Drug Addiction, 2005.
40. Majer J, Jason L, Ferrari J, et al: Comorbidity among Oxford House residents: a preliminary outcome study. Addictive Behaviors 27:837-845, 2002.
41. van Limbeek J, Wouters L, Kaplan C, et al: Prevalence of psychopathology in drug-addicted Dutch. Journal of Substance Abuse Treatment 9:43-52, 1992.
42. Alonso J, Angermeyer MC, Bernert S, et al: Prevalence of mental disorders in Europe: results from the European study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 109:21-27, 2004.
43. Franken I, Hendriks V: Screening and diagnosis of anxiety and mood disorders in substance abuse patients. The American Journal on Addictions 10:30-39, 2001.
44. Landheim AS, Bakken K, Vaglum P: Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics - Substance abusers treated in two counties in Norway. European Addiction Research 9:8-17, 2003.
45. Bijl R, de Graaf R, Hiripi E, et al: The prevalence of treated and untreated mental disorders in five countries. Health Affairs 22:122-133, 2003.
46. Cottler L, Nishith P, Compton W: Gender differences in risk factors for trauma exposure and post-traumatic stress disorder among inner-city drug abusers in and out of treatment. Comprehensive Psychiatry 42:111-117, 2001.
47. Stalenheim E, vanKnorring L: Psychopathy and axis I and axis II psychiatric disorders in a forensic psychiatric population in Sweden. Acta Psychiatrica Scandinavica 94:217-223, 1996.
48. Hser YI, Huang D, Teruya C, et al: Gender comparisons of drug abuse treatment outcomes and predictors. Drug and Alcohol Dependence 72:255-264, 2003.
49. Watkins K, Hunter S, Wenzel S, et al: Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American Journal of Drug and Alcohol Abuse 30:749-764, 2004.
50. Cohen S, Wills TA: Stress, social support and the buffering hypothesis. Psychological Bulletin 98:319-357, 1985.
51. House JS, Landis KR, Umberson D: Social relationships and health. Science 241:540-545, 1988.
52. Moos RH, Moos BS, Andrassy JM: Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatric Services 50:1577-1583, 1999.
53. Mueser K, Drake R, Miles K: The course and treatment of substance use disorder in persons with severe mental illness, in Treatment of Drug-dependent Individuals with Comorbid Mental Disorders. Edited by Onken L, Blaine J, Genser S, Horton A. Rockville MD, National Institute on Drug Abuse (NIDA), 1997.
54. Brunette MF, Mueser KT, Drake RE: A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review 23:471-481, 2004.
55. De Leon G, Jainchill N: Male and female drug abusers: social and psychological status 2 years after treatment in a therapeutic community. American Journal of Drug and Alcohol Abuse 8:465-497, 1982.
56. Marsden J, Gossop M, Stewart D, et al: Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. The British Journal of Psychiatry 176:285-9, 2000.